Lactobacillus paracasei F19
Lactobacillus paracasei F19 is a probiotic strain that has been studied in human feeding studies spanning multiple cohorts. A randomized controlled trial investigated its role in the context of gastrointestinal side effects associated with proton pump inhibitor use, and early-life intervention studies have examined tolerability in infants and children. Most mechanistic research is in vitro, exploring growth in the presence of prebiotics and behavior under food-processing conditions such as microwave drying and incorporation into fermented foods. Evidence for specific health benefits remains preliminary and mostly preclinical or exploratory. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 25 body-system-tagged papers that concern each system. Research coverage, not measured effect.
+2 more systems
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 13 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
+4 more symptoms
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
39 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 42574976 →Engineered PEA-producing Lactobacillus paracasei F19 prevents colitis-associated colorectal cancer in mice by modulating inflammatory–angiogenic signaling and beneficially reshapes gut microbiota composition· Biomedicine & Pharmacotherapy · 2026
-
[2]
PMID 35558362 →Metabolic Phenotype and Microbiome of Infants Fed Formula Containing Lactobacillus paracasei Strain F-19· Frontiers in Pediatrics · 2022
-
[3]
PMID 25660822 →Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: A randomized clinical trial· Digestive and Liver Disease · 2015
-
[4]
PMID 21372765 →Efficacy of Lactobacillus paracasei sub. paracasei F19 on abdominal symptoms in patients with symptomatic uncomplicated diverticular disease: a pilot study.· Computer Und Recht: Forum für die Praxis des Rechts der Datenverargeitung, Information und Automation · 2011
-
[5]
Source →Lactobacillus paracasei subsp. paracasei F19: Survival, Ecology and Safety in the Human Intestinal Tract - A Survey of Feeding Studies within the PROBDEMO Project· Microbial Ecology in Health and Disease · 2002
-
[6]
Source →Isolation, Selection and Characteristics of Lactobacillus paracasei subsp. paracasei F19· Microbial Ecology in Health and Disease · 2002